Based on the BioGPS database to assess the mRNA levels of 7 hub targets, the hub targets had elevated mRNA levels in lung cancer-related organs, including lung, SmoothMuscle, Cd34+ cells, cd33+ cells and Cd56+ cells. This evidence concerns the gene CD33 and lung carcinoma.